Schonfeld Strategic Advisors LLC Adaptive Biotechnologies Corp Transaction History

Schonfeld Strategic Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $169,600 - $390,345	-26,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.12 - $28.9 $98,163 - $280,330	-9,700 Reduced 26.8%	26,500 $368,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $911,154 - $1.33 Million	36,200 New	36,200 $1.02 Million
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $937,988 - $1.3 Million	-29,112 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $1.08 Million - $1.97 Million	29,112 New	29,112 $1.17 Million
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $2.25 Million - $3.27 Million	-50,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $1.03 Million - $1.41 Million	28,900 Added 136.97%	50,000 $2,000
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $526,445 - $1.02 Million	21,100 New	21,100 $1.02 Million
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $734,344 - $980,719	-29,900 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$30.31 - $53.51 $2.64 Million - $4.65 Million	-86,945 Reduced 74.41%	29,900 $925,000
Q2 2019 Aug 14, 2019	BUY	$40.3 - $48.3 $4.71 Million - $5.64 Million	116,845 New	116,845 $5.64 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.